249 filings
Page 9 of 13
8-K
duzm6 lgk8qo
21 Feb 12
Threshold Pharmaceuticalsannounces Positive Phase 2B Clinical Trial Results of TH-302 In Patients with Pancreatic Cancer
12:00am
8-K
xr58u7 98bgxqoob3q
21 Feb 12
Departure of Directors or Certain Officers
12:00am
8-K
g86oj64c6xd4j
3 Feb 12
Entry into a Material Definitive Agreement
12:00am
8-K
b4w8ma5am455 k4lu
20 Jan 12
Entry into a Material Definitive Agreement
12:00am
8-K
fajlkovj9xuz6cnx1w
14 Dec 11
Threshold Pharmaceuticals Announces Promising Phase 1 Clinical Trial Results In Patients with Advanced Leukemias
12:00am
8-K
1gdl91q3pk3rw vp
14 Dec 11
Threshold Pharmaceuticals Announces Update to TH-302 Pancreatic Data to Be Presented at the Oppenheimer Healthcare Conference
12:00am
8-K
yykd1zalw
28 Oct 11
Other Events
12:00am
8-K
elluhes9 zix42
30 Sep 11
Other Events
12:00am
8-K
d0u8yv5rkwvuohhwgdjx
27 Jul 11
Entry into a Material Definitive Agreement
12:00am
8-K
0t1hw5btrt
25 Jul 11
Other Events
12:00am
8-K
m7x z9dhc6gqb1
6 Jul 11
Other Events
12:00am
8-K
4xdukovx83
29 Jun 11
Other Events
12:00am
8-K
5q7pkyduvk9r
24 Jun 11
Threshold Pharmaceuticals Announces Completion of Patient Recruitment for Phase 2 TH-302 Pancreatic Cancer Study
12:00am
8-K
134qmehugu23vsm
6 Jun 11
Other Events
12:00am
8-K
io1tix
1 Jun 11
Departure of Directors or Certain Officers
12:00am
8-K
lsj8u3lk
27 May 11
Submission of Matters to a Vote of Security Holders
12:00am
8-K
2lxvhdmt5 o6fxfs
25 Apr 11
Other Events
12:00am
8-K
uo93n962ro
21 Apr 11
Other Events
12:00am
8-K
o2i y23myajasebf
14 Apr 11
Changes in Registrant's Certifying Accountant
12:00am
8-K
t2m8x6p3y0t74
11 Mar 11
Entry into a Material Definitive Agreement
12:00am